What Happened?
Ewing, NJ-based Peter Graham as Senior Vice President, Human Resources
About the Company
Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.
About the Person
Peter J. Graham is the Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary at Antares Pharma, Inc. since July 2015. Mr. Graham was most recently Executive Vice President, General Counsel, Chief Compliance Officer and Global Human Resources of Delcath Systems, Inc., where he directed the global legal, compliance and human resource functions. Prior to Delcath, Mr. Graham was Vice President, General Counsel and a member of the Executive Committee of ACIST Medical Systems, Inc., a global company specializing in diagnostic and therapeutic medical devices for cardiology and radiology. There, he led the corporate accounts and global legal affairs of the company, playing a significant role in helping to expand the company`s corporate contract business and international distribution network and the $80 million acquisition of HLT, Inc. Prior to that, Mr. Graham spent 11 years at E-Z-EM, Inc., a global medical device and pharmaceutical company specializing in CT and MR imaging solutions. During his tenure at E-Z-EM, Mr. Graham held various senior management positions serving as its Senior Vice President, Chief Legal Officer, Global Human Resources and Secretary from 2005 until 2008. Mr. Graham played a key role in the sale of E-Z-EM in 2008 leading and coordinating the legal and investment banking activities associated with the sale. He also managed the legal affairs of AngioDynamics, Inc., then a wholly owned subsidiary of E-Z-EM from 1997 until its initial public offering and tax free spin off in 2004. Mr. Graham was on the Board of Directors of AngioDynamics from 2006 to 2007, and was instrumental in the company`s successful $75 million follow-on offering, and its acquisition of Rita Medical Systems, Inc. for $220 million during that time frame. Before his time with E-Z-EM, Mr. Graham was an associate at Segal and Lax, P.C. He earned his J.D. at Yeshiva University`s Benjamin N. Cardozo School of Law in 1995, and his B.A. at the University of Wisconsin-Madison.
Info Source
News
Short Profile